Sasso, Ferdinando Carlo

Microplastics and Nanoplastics in Atheromas and Cardiovascular Events

Marfella, R., Prattichizzo, F., Sardu, C., Fulgenzi, G., Graciotti, L., Spadoni, T., D’Onofrio, N., Scisciola, L., La Grotta, R., Frigé, C., et al. (2024) · New England Journal of Medicine

Microplastics and Plastic PollutionCerebrovascular and Carotid Artery Diseases

Cited by 1,223

Oxidative Stress in Type 2 Diabetes: Impacts from Pathogenesis to Lifestyle Modifications

Caturano, A., D’Angelo, M., Mormone, A., Russo, V., Mollica, M. P., Salvatore, T., Galiero, R., Rinaldi, L., Vetrano, E., Marfella, R., et al. (2023) · Current Issues in Molecular Biology

Antioxidant Activity and Oxidative StressNitric Oxide and Endothelin Effects

Cited by 579

GLP-1 Receptor Agonists in Non-Alcoholic Fatty Liver Disease: Current Evidence and Future Perspectives

Nevola, R., Epifani, R., Imbriani, S., Tortorella, G., Aprea, C., Galiero, R., Rinaldi, L., Marfella, R., & Sasso, F. C. (2023) · International Journal of Molecular Sciences

Liver Disease Diagnosis and TreatmentDiabetes Treatment and Management

Cited by 286

The Diabetic Cardiomyopathy: The Contributing Pathophysiological Mechanisms

Salvatore, T., Pafundi, P. C., Galiero, R., Albanese, G., Di Martino, A., Caturano, A., Vetrano, E., Rinaldi, L., & Sasso, F. C. (2021) · Frontiers in Medicine

Cardiovascular Function and Risk FactorsCardiac Fibrosis and Remodeling

Cited by 165

Glucose metabolism and coronary heart disease in patients with normal glucose tolerance

Sasso, F. C. (2004) · JAMA

Diabetes, Cardiovascular Risks, and LipoproteinsCardiovascular Function and Risk Factors

Cited by 117

Autonomic dysfunction is associated with brief episodes of atrial fibrillation in type 2 diabetes

Rizzo, M. R., Sasso, F. C., Marfella, R., Siniscalchi, M., Paolisso, P., Carbonara, O., Capoluongo, M. C., Lascar, N., Pace, C., Sardu, C., et al. (2015) · Journal of Diabetes and its Complications

Atrial Fibrillation Management and OutcomesHeart Rate Variability and Autonomic Control

Cited by 100

Coronary Microvascular Dysfunction in Diabetes Mellitus: Pathogenetic Mechanisms and Potential Therapeutic Options

Salvatore, T., Galiero, R., Caturano, A., Vetrano, E., Loffredo, G., Rinaldi, L., Catalini, C., Gjeloshi, K., Albanese, G., Di Martino, A., et al. (2022) · Biomedicines

Cardiovascular Function and Risk FactorsCardiac Imaging and Diagnostics

Cited by 98

Can Metformin Exert as an Active Drug on Endothelial Dysfunction in Diabetic Subjects

Salvatore, T., Pafundi, P. C., Galiero, R., Rinaldi, L., Caturano, A., Vetrano, E., Aprea, C., Albanese, G., Di Martino, A., Ricozzi, C., et al. (2020) · Biomedicines

Nitric Oxide and Endothelin EffectsDiabetes Treatment and Management

Cited by 97

Results of the safety run-in part of the METAL (METformin in Advanced Lung cancer) study: A multicentre, open-label phase I-II study of metformin with erlotinib in second-line therapy of patients with stage IV non-small-cell lung cancer

Morgillo, F., Fasano, M., Della Corte, C. M., Sasso, F. C., Papaccio, F., Viscardi, G., Esposito, G., Di Liello, R., Normanno, N., Capuano, A., et al. (2017) · ESMO Open

Lung Cancer Treatments and MutationsMetabolism, Diabetes, and Cancer

Cited by 76

Does a strict glycemic control during acute coronary syndrome play a cardioprotective effect? Pathophysiology and clinical evidence

Caturano, A., Galiero, R., Pafundi, P. C., Cesaro, A., Vetrano, E., Palmiero, G., Rinaldi, L., Salvatore, T., Marfella, R., Sardu, C., et al. (2021) · Diabetes Research and Clinical Practice

Hyperglycemia and glycemic control in critically ill and hospitalized patientsDiabetes Treatment and Management

Cited by 73

Irbesartan Reduces the Albumin Excretion Rate in Microalbuminuric Type 2 Diabetic Patients Independently of Hypertension

Sasso, F. C., Carbonara, O., Persico, M., Iafusco, D., Salvatore, T., D’Ambrosio, R., Torella, R., & Cozzolino, D. (2002) · Diabetes Care

Chronic Kidney Disease and DiabetesBlood Pressure and Hypertension Studies

Cited by 73

Effects of insulin-glucose infusion on left ventricular function at rest and during dynamic exercise in healthy subjects and noninsulin dependent diabetic patients

Sasso, F. C., Carbonara, O., Cozzolino, D., Rambaldi, P., Mansi, L., Torella, D., Gentile, S., Turco, S., Torella, R., & Salvatore, T. (2000) · Journal of the American College of Cardiology

Cardiovascular Function and Risk FactorsDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 66

Dysregulated epicardial adipose tissue as a risk factor and potential therapeutic target of heart failure with preserved ejection fraction in diabetes

Salvatore, T., Galiero, R., Caturano, A., Vetrano, E., Rinaldi, L., Coviello, F., Di Martino, A., Albanese, G., Colantuoni, S., Medicamento, G., et al. (2022) · Biomolecules

Cardiovascular Disease and AdiposityCardiovascular Function and Risk Factors

Cited by 62

Effects of insulin on left ventricular function during dynamic exercise in overweight and obese subjects

Sasso, F. C., Carbonara, O., Nasti, R., Marfella, R., Esposito, K., Rambaldi, P., Mansi, L., Salvatore, T., Torella, R., & Cozzolino, D. (2005) · European Heart Journal

Cardiovascular Function and Risk FactorsDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 20

Factors affecting long-term changes of liver stiffness in direct-acting anti-hepatitis C virus therapy: A multicentre prospective study

Rosato, V., Ascione, A., Nevola, R., Fracanzani, A. L., Piai, G., Messina, V., Claar, E., Coppola, C., Fontanella, L., Lombardi, R., et al. (2022) · Journal of Viral Hepatitis

Hepatitis C virus researchLiver Disease Diagnosis and Treatment

Cited by 17

Diabetic Gastroparesis: Navigating Pathophysiology and Nutritional Interventions

Caturano, A., Cavallo, M., Nilo, D., Vaudo, G., Russo, V., Galiero, R., Rinaldi, L., Marfella, R., Monda, M., Luca, G., et al. (2024) · Gastrointestinal Disorders

Gastrointestinal motility and disordersEnhanced Recovery After Surgery

Cited by 17